WuXi Biologics (Cayman) Inc. (HKG:2269)
23.10
+0.55 (2.44%)
May 9, 2025, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
1.58M HKD
Profits / Employee
284.01K HKD
Market Cap
91.59B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
Innovent Biologics | 5,659 |
Alibaba Health Information Technology | 1,435 |
Akeso | 2,778 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Sino Biopharmaceutical | 24,379 |
WuXi Biologics News
- 10 days ago - Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report - PRNewsWire
- 17 days ago - WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year - PRNewsWire
- 21 days ago - WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou ... - GuruFocus
- 21 days ago - WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site - PRNewsWire
- 25 days ago - WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards - PRNewsWire
- 6 weeks ago - Wuxi Biologics ADR reports FY results - Seeking Alpha
- 6 weeks ago - WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 - PRNewsWire
- 6 weeks ago - WuXi Biologics Celebrates Eighth Consecutive CDMO Leadership Award Win - GuruFocus